We continued the analysis focusing on NLR, MLR, total proteins, gammaglobulins, C3 and C4 and vitamin D—all parameters that revealed statistically significant differences in patients who developed PN during the follow-up period. The gene discussed is C3; the disease is poikiloderma with neutropenia.